Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil T Darras

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
International Journal of Neonatal Screening|June 2, 2021
Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular AtrophyJaime E Hale, Basil T Darras, Kathryn J Swoboda, et al.
Journal of Neuromuscular Diseases|February 13, 2023
Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported OutcomesSally Dunaway Young, Amy Pasternak, Tina Duong, et al.
Molecular Genetics & Genomic Medicine|January 29, 2019
Identification of a pathogenic mutation in ATP2A1 via in silico analysis of exome data for cryptic aberrant splice sitesChristine C Bruels, Chengcheng Li, Tonatiuh Mendoza, et al.
Frontiers in Neurology|August 6, 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyThomas O Crawford, John W Day, Darryl C De Vivo, et al.
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
The New England Journal of Medicine|February 24, 2021
Risdiplam in Type 1 Spinal Muscular AtrophyGiovanni Baranello, Basil T Darras, John W Day, et al.
Pediatric Neurology|May 31, 2022
Nusinersen for Patients With Spinal Muscular Atrophy: 1415 Doses via an Interdisciplinary Institutional ApproachElena Madan, Sabrina Carrié, Carolina Donado, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
The New England Journal of Medicine|July 28, 2021
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical ControlsBasil T Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, et al.
Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
International Journal of Neonatal Screening|June 2, 2021
Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular AtrophyJaime E Hale, Basil T Darras, Kathryn J Swoboda, et al.
Journal of Neuromuscular Diseases|February 13, 2023
Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported OutcomesSally Dunaway Young, Amy Pasternak, Tina Duong, et al.
Molecular Genetics & Genomic Medicine|January 29, 2019
Identification of a pathogenic mutation in ATP2A1 via in silico analysis of exome data for cryptic aberrant splice sitesChristine C Bruels, Chengcheng Li, Tonatiuh Mendoza, et al.
Frontiers in Neurology|August 6, 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyThomas O Crawford, John W Day, Darryl C De Vivo, et al.
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
The New England Journal of Medicine|February 24, 2021
Risdiplam in Type 1 Spinal Muscular AtrophyGiovanni Baranello, Basil T Darras, John W Day, et al.
Pediatric Neurology|May 31, 2022
Nusinersen for Patients With Spinal Muscular Atrophy: 1415 Doses via an Interdisciplinary Institutional ApproachElena Madan, Sabrina Carrié, Carolina Donado, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
The New England Journal of Medicine|July 28, 2021
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical ControlsBasil T Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, et al.
Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.
Pageof 23